Pharmaceuticals

Global Pneumococcal Vaccines Market 2014-2018

  • TEC169910
  • 64 Pages
  • September 2014
  • Pharmaceuticals
About Pneumococcal Disease and Its Prevention
Pneumococcus (Streptococcus pneumonia), a pathogenic bacterium, is the leading cause of serious illness across the globe. It is the main cause of pneumonia, sinusitis, blood infections, meningitis, and middle ear infections (otitis media). Pneumococcal disease affects children and the elderly, and it is one of the leading infectious diseases worldwide. It kills almost 1.6 million people (including more than 800,000 children under the age five years) every year. Pneumococcal disease can be prevented by vaccination. Vaccination involves the introduction of dead or weakened antigen into the human body, which in turn produces lymphocytes to counter the infection and any future invasions by that antigen.
TechNavio's analysts forecast the Global Pneumococcal Vaccines market to grow at a CAGR of 4.90 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Pneumococcal Vaccines market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various vaccines administered to actively immunize pneumococcal disease caused by different serogroups of Streptococcus pneumonia.
TechNavio's report, the Global Pneumococcal Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Pneumococcal Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
Americas
APAC
EMEA
Key Vendors
GlaxoSmithKline
Merck
Pfizer
Other Prominent Vendors

Lupin
Sanofi Pasteur MSD
S K Chemicals
Market Driver
Included Vaccine in National Immunization Schedule
For a full, detailed list, view our report
Market Challenge
Inadequate Coverage of Vaccine
For a full, detailed list, view our report
Market Trend
Increase in Strategic Alliances
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Human Insulin Market (Product Type, Brand and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Oral Proteins and Peptides Market (Drugs, technology, geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast, 2013 - 2020

Oral Proteins and Peptides are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Neuroprotective Products Market (Class of Drugs, Treatment of Medical Conditions and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Antipsychotic Drugs Market (Brand, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Markets for Antifungal Agents (Anti - Infective) - Industry Analysis, Share, Size, Trends, Opportunities and Forecast, 2012 - 2020

High penetration of conventional drugs used in the treatment of fungal diseases is reducing the growth for anti-fungal agent market. Though these restraints are dominating the market, the application of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>